| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 06/08/2005 | EP1536850A1 Medical device having hydration inhibitor |
| 06/08/2005 | EP1536843A2 Radiolabeled compounds and liposomes and their methods of making and using the same |
| 06/08/2005 | EP1536839A2 Method for treating diseases with omega interferon |
| 06/08/2005 | EP1536834A2 Design of chemokine analogs for the treatment of human diseases |
| 06/08/2005 | EP1536829A2 Methods for preparing compositions comprising heat shock proteins or alpha-2-macroglobulin useful for the treatment of cancer and infectious disease |
| 06/08/2005 | EP1536828A2 Methods of delivery of exogenous proteins to the cytosol and uses thereof |
| 06/08/2005 | EP1536827A1 Use of protein kinase n beta |
| 06/08/2005 | EP1536816A2 Amelioration of effects of cigarette smoke |
| 06/08/2005 | EP1536813A2 Compositions and methods comprising protein activated receptor antagonists |
| 06/08/2005 | EP1536808A2 Heterocarpin, a plant-derived protein with anti-cancer properties |
| 06/08/2005 | EP1536787A2 Imidazole alkaloids from lepidium meyenii and methods of usage |
| 06/08/2005 | EP1536779A2 Treatment of metastatic breast cancer with anthracyclines and taxanes |
| 06/08/2005 | EP1536778A2 Proteins binding to cross-beta structure comprising amyloid and methods for detection and modulation of the cross-beta structure, its formation and its associated toxicity |
| 06/08/2005 | EP1536768A1 Biodegradable composition with prolonged release of the biological active compound and preparation thereof |
| 06/08/2005 | EP1458706A4 Diaryl 1,2,4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 06/08/2005 | EP1373269B1 Jun kinase inhibitors |
| 06/08/2005 | EP1309575B1 Biphenyl derivatives and their use as ppar-gamma receptor activators |
| 06/08/2005 | EP1268306A4 Inverted aerosol dispenser |
| 06/08/2005 | EP1265595B1 Stabilized ascorbic acid solutions |
| 06/08/2005 | EP1259514B1 3-(pyrolyllactone)-2-indolinone compounds as kinase inhibitors |
| 06/08/2005 | EP1252133B1 Pharmaceutical compounds |
| 06/08/2005 | EP1251858B1 Podophyllotoxin compositions |
| 06/08/2005 | EP1102775B1 Novel phospholipids with unsaturated alkyl and acyl chains |
| 06/08/2005 | EP1069919B1 Stimulus sensitive gel comprising a radioisotope and methods of making such gel |
| 06/08/2005 | EP1015459B1 Tetrazole-containing rapamycin analogs with shortened half-lives |
| 06/08/2005 | EP1001797B1 Soya extract, process for its preparation and pharmaceutical composition |
| 06/08/2005 | EP0997152B1 Antibodies as REMEDIES FOR LYMPHOCYTIC TUMORS (EXCEPT MYELOMA) |
| 06/08/2005 | EP0793504B1 Chimeric cytokines and uses thereof |
| 06/08/2005 | CN1625603A Genetic polymorphisms in the preprotachykinin gene |
| 06/08/2005 | CN1625565A Antibodies to non-functional P2X7 receptor, diagnosis and treatment of cancers and other conditions |
| 06/08/2005 | CN1625559A Novel compounds that inhibit factor Xa activity |
| 06/08/2005 | CN1625555A Quinazoline compounds |
| 06/08/2005 | CN1625554A Amides of aminoalkyl substituted azetidines, pyrrolidines, piperidines and azepanes |
| 06/08/2005 | CN1625407A Medicine composition comprising arsenite for treatment of malignancy |
| 06/08/2005 | CN1624128A Death domain containing receptor 5 antibodies |
| 06/08/2005 | CN1623993A Cantharides amine and demethyl cantharides amine derivative and application in medicine thereof |
| 06/08/2005 | CN1623594A Powder for treating oophoritic cyst |
| 06/08/2005 | CN1623580A Medicine for treating cancer |
| 06/08/2005 | CN1623553A Anticancer auxiliary medicine using 20 (S)-panaxcoside Rg3 as effertive component and its application |
| 06/08/2005 | CN1623550A Hydroxy progesterone caproate oral preparation and its use |
| 06/08/2005 | CN1623547A Medical use of artificial lywrine |
| 06/08/2005 | CN1623543A Organic compounds |
| 06/08/2005 | CN1623541A Application of aloelactone in preparation of medicine |
| 06/08/2005 | CN1623540A Unit dose form cantharide acid freeze-dried powder injection preparation and its preparation method |
| 06/08/2005 | CN1205336C Novel ribozyme of specificity cutting survivin, its medicinal composition and use |
| 06/08/2005 | CN1205225C Human protein with cancer inhibiting function and its coding sequence |
| 06/08/2005 | CN1205219C Unsaturated 14,15-cyclopropane-cendrostanes, a method for their production and pharmaceutical compositions containing these compounds |
| 06/08/2005 | CN1205208C C-21 modified epothilones |
| 06/08/2005 | CN1205205C Sodium-hydrogen exchanger type 1 inhibitor crystals |
| 06/08/2005 | CN1205184C Beta-lactan |
| 06/08/2005 | CN1205181C Matrix metalloproteinase inhibitors |
| 06/08/2005 | CN1205166C Synthesis of antitumour medicine 4-[1-(3,5,8,8-petamethyl-5,6,7,8-tetrahydro-2-naphthyl) ethenyl] benzoic acid |
| 06/08/2005 | CN1204924C Liquid composition of biodegradable block copolymer for drug delivery system and process for preparation thereof |
| 06/08/2005 | CN1204911C Orally taken Chinese patent drug for treating endocrine dyscrasia |
| 06/08/2005 | CN1204897C Licorice polysaccharide powder-injection |
| 06/08/2005 | CN1204895C Etoposide enteric slow (controlled) release solid dispersing preparation and its preparation method |
| 06/08/2005 | CN1204894C Anticancer application of 2-methoxy estradiol, Neomycin sulfate and their mixture |
| 06/08/2005 | CN1204893C Pharmaceutical composition |
| 06/08/2005 | CN1204892C Formulations for reducing or eliminating toxicity of environmental hormones containing ursodeoxycholic acid |
| 06/08/2005 | CN1204889C Adhesion receptor antagonists |
| 06/08/2005 | CN1204888C Usage of indole derivatives for treating tumours |
| 06/08/2005 | CN1204886C Condensation derivatives of thiocolchicine and baccatin and its composition |
| 06/08/2005 | CN1204884C N-acetyl-L cysteine for preparing medicine for treating epithelial tumous |
| 06/08/2005 | CN1204881C Use of allylamine derivatives in the manufacture of a medicament for the treatment of helicobacter pylori infection and correlation diseases |
| 06/07/2005 | US6903215 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 06/07/2005 | US6903203 Immunoglobulin for use in the diagnosis and therapy of cancer |
| 06/07/2005 | US6903137 Agonists specific for the peripheral cannabinoid receptor |
| 06/07/2005 | US6903132 Non-peptide GnRH agents, pharmaceutical compositions and methods for their use |
| 06/07/2005 | US6903131 Administering to a patient an antiangiogenesis or anticancer agent (N,N-disubstituted-3,4-diamino-2,4-dione-pyrroline derivatives for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer |
| 06/07/2005 | US6903122 Crystals of benzimidazole compounds |
| 06/07/2005 | US6903121 Treatment of tumors with acetylenes disubstituted with a phenyl or heteroaromatic group and a substituted chromanyl, thiochromanyl or tetrahydroquinolinyl group in combination with other anti-tumor agents |
| 06/07/2005 | US6903107 Serine protease inhibitor |
| 06/07/2005 | US6903102 17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 06/07/2005 | US6903098 Use of phthalazine derivatives |
| 06/07/2005 | US6903088 Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 06/07/2005 | US6903081 Phosphoramidates and methods therefor |
| 06/07/2005 | US6902908 Polypeptides, fusion proteins; includes production and use recombinant expression constructs having regulated promoter; mitochondria |
| 06/07/2005 | US6902885 For detecting viral and cellular polypeptide interactions |
| 06/07/2005 | US6902748 Medicines manufactured from old platycodon extracts |
| 06/07/2005 | US6902731 Transcription factors; for arterial administration via stent |
| 06/07/2005 | CA2348026C Antibodies against semp1, methods for their production and uses thereof |
| 06/07/2005 | CA2332686C Novel 13 and 14-membered antibacterial and prokinetic macrolides and their intermediates |
| 06/07/2005 | CA2320180C Cyclohexanediole derivatives |
| 06/07/2005 | CA2244139C Distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents |
| 06/07/2005 | CA2209598C Aryl and heteroaryl purine compounds |
| 06/07/2005 | CA2186731C Trinuclear cationic platinum complexes having antitumour activity and pharmaceutical compositions containing them |
| 06/07/2005 | CA2153135C Method for obtaining modified immunoglobulins with reduced immunogenicity of murine antibody variable domains and compositions containing them |
| 06/07/2005 | CA2068790C Antiviral compounds |
| 06/02/2005 | WO2005049008A1 Combinational radiotherapy and chemotherapy compositions and methods |
| 06/02/2005 | WO2005049001A1 Anti-tumour terpene compounds |
| 06/02/2005 | WO2005026170A3 Uses of neuronal pannexins for therapy and diagnosis in mammals |
| 06/02/2005 | WO2005019220A9 Substituted imidazo[1,2-a]pyrazines as modulators of kinase activity |
| 06/02/2005 | WO2005009961B1 Fluoro substituted omega-carboxyaryl diphenyl urea for the treatment and prevention of diseases and conditions |
| 06/02/2005 | WO2004074324A3 Modulation of the poliovirus receptor function |
| 06/02/2005 | WO2004066947B1 Hyperthermia oncolysis co-therapy |
| 06/02/2005 | WO2004037182A3 Active specific immunotherapy of cancer metastasis |
| 06/02/2005 | WO2004011456A9 Protein tyrosine kinase inhibitors |
| 06/02/2005 | WO2003075847A3 NOVEL CURCUMINOID-FACTOR VIIa CONSTRUCTS AS SUPPRESSORS OF TUMOR GROWTH AND ANGIOGENESIS |
| 06/02/2005 | US20050119484 Mitotic kinesin inhibitors |
| 06/02/2005 | US20050119474 Geranyl compounds |